VACCINEX, INC.·4

Nov 18, 4:05 PM ET

Zauderer Maurice 4

4 · VACCINEX, INC. · Filed Nov 18, 2024

Insider Transaction Report

Form 4
Period: 2024-11-14
Zauderer Maurice
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Common Stock

    2024-11-14$3.25/sh+46,153$149,997297,941 total(indirect: By Vaccinex (Rochester), L.L.C.)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $615.30Exp: 2031-04-02Common Stock (66 underlying)
    66
  • Stock Option (Right to Buy)

    Exercise: $92.26Exp: 2028-03-30Common Stock (266 underlying)
    266
  • Stock Option (Right to Buy)

    Exercise: $270.90Exp: 2032-04-01Common Stock (133 underlying)
    133
  • Stock Option (Right to Buy)

    Exercise: $1491.00Exp: 2025-12-23Common Stock (15 underlying)
    15
  • Common Stock

    (indirect: By Trust)
    1,011
  • Common Stock

    1,580
  • Common Stock

    (indirect: By Trust)
    1,016
  • Stock Option (Right to Buy)

    Exercise: $1402.80Exp: 2025-02-24Common Stock (135 underlying)
    135
  • Warrant (Right to Buy)

    (indirect: By Vaccinex (Rochester), L.L.C.)
    Exercise: $5.64From: 2024-09-18Exp: 2029-09-18Common Stock (170,475 underlying)
    170,475
  • Stock Option (Right to Buy)

    Exercise: $8.21Exp: 2034-03-21Common Stock (1,877 underlying)
    1,877
Footnotes (7)
  • [F1]Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
  • [F2]Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]Exercisable in full as of the date of this report.
  • [F4]This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
  • [F5]This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
  • [F6]This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
  • [F7]This option vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date, except as otherwise provided in the award notice.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES